food and drug administration has approved burroughs wellcome azt treatment help certain aids patients including those with advanced aids related complex drug first approved treatment for aids azt azidothymidine will marketed retrovir company arm britain because its limited supply fda said drug will restricted initially those patients with aids aids related complex with severely depressed immunity history pnumocystis carinii pneumonia today approval marks important step but means final victory against ongoing war against aids said robert windom assistant secretary for health public health service noted available clinical data were sufficient for approving retrovir only for certain indications and not for all aids associated conditions nevertheless windom said today action means significant medical relief will available thousands those afflicted with disease retrovir not cure but has demonstrated ability improve short term survival aids patients with recently diagnosed pcp pneumomystis carinii pneumonia and certain patients with advanced arc aids related complex said windom advanced aids related complex condition frequently precedes and develops within short time into full scale acquired immune deficiency syndrome march were 825 aids cases reported nationwide with more 000 deaths public health agency said advanced arc patients have symptoms include weight loss persistent fever and diarrhea and less severe infections such oral thrush and herpes infections federal agency said aids patients expected qualify for retrovir treatment those have serious opportunistic infections associated with aids and those with advanced aids related complex estimated about two three times many americans may suffer from advanced arc from aids burroughs wellcome research triangle park has scheduled press conference for monday new york will discuss patients will quality for treatment company has said year treatment with drug would cost 000 dlrs 000 dlrs burroughs has also said has adequate supplies drug for most seriously ill patients and will have supplies for minimum 000 patients and probably more end year retrovir approval was expected panel expert medical advisers fda recommended january drug licensed for sale even were gaps understanding drug effectiveness panel said drug could prolong lives certain aids patients but also caused severe side effects such anemia and blood problems due extraordinary situation surrounding aids fatal disease reaching some health officials epidemic proportions windom said fda has moved near record time four months approve drug azt derived from herring sperm was created 1960s jerome horwitz michigan cancer foundation anticancer agent meanwhile london dealers said wellcome shares rose 497p response from last night close 457p but pharmaceutical analyst mark clark barclays zoete wedd said new drug share market may not high expected since had very severe side effects not cure and side effects bad unlikely someone could support full year treatment said also whole host drugs likely onto market quite soon last week drug was approved for marketing reuter 